THE SWEDISH-AMERICAN LIFE SCIENCE
SUMMIT 2010

was held in Stockholm in September 29 – October 1, 2010
in Stockholm, Sweden

Nobel Laurate Dr. Gerald M Edelman, Mr. John Costantino, Ms Barbro C. Ehnbom and
Dr. Karin Hehenberger

I would like to extend a warm thank you to all our participants in making SALSS 2010 the best Summit to date. I hope to see you all again next year, when we move back toward our summer format. Please save the date August 24-26 for SALSS 2011!

All the best,

Latest SALSS News

SALSS pictures from Biotech Sweden �

Pictures from Dr. Daniel Kraft �

SALSS Send-Off Dinner 2010
SALSS Send-off dinner 2010 at the residence of new Swedish Consul General in New York David Dangoor in June 30 was a huge success!

Impressions from SALSS 2010

The Swedish American Life Science Summit is a unique and provocative forum that is life-like in its organization, pulling together people, science and ideas. Nobel Laureate Professor Gerald Edelman keynoted this year’s Summit with his presentation CONSCIOUSNESS – How Matter Becomes Imagination. His lecture set the stage for the Summit by providing the scientific and neural basis of brain origins of imagination, and that those brain origins required for science, do not differ for humanities, and ethical systems. Given the program presentations that included exponential trends in life science, converging technologies and biotech financing, a welcome and delightful “maestoso” was found in presentations of music cognition and neuroscience. The “maestoso” afforded the participants the opportunity to begin to understand the intersection of man’s scientific and humanistic imagination that will allow the scientific frontier to fully expand.
Charles Ferris,
Strategic Science LLC

Thank you for a great meeting. Yet again you have inspired us and brought together leaders with different perspectives on important challenges and opportunities in our favorite industry. I came away with many ideas and some new contacts to explore further in the business I lead.
Stefan Larsson,
the Boston Consulting Group

It was a terrific SALSS event this year. It's remarkable that you are able to bring together such amazing people to share their stories and ideas. To building more bridges!
Andrew Hessel,
Singularity University

SALSS 2010 was very well run and truly informative. For me it was an opportunity to meet very impressive individuals and companies from the Swedish life science sectors that until now I have not been exposed to. I was indeed very impressed with the high level that the science has achieved in Sweden.
David Fuchs,
Bridges and Pipes

It was an extraordinary group of people, companies, and presentations. The intellectual capital in the room is overwhelming. I have been inspired by the amount of research being done in neuroscience and the arts combined. I do hope that many companies' and scientists receive the funding and resources to continue their good works. I don't know how you do it! You are a force!
Julie Muraco,
Praeditis Group LLC

Stort tack f�r att Du bj�d in mig till SALSS-m�tet som var mycket bra och dessutom trevligt. Jag fick l�ra k�nna m�nga intressanta m�nniskor och dessutom var programmet v�l utformat. Det �r s�llan som man kan ge en konferens eller dess organisat�r s� fina betyg.
Uli Hacksell,
Acadia Pharmaceuticals

I would also like to thank you for a wonderful event that was so very well organized. I was truly amazed at your ability to combine science with industry. Thanks once again for the invitation.
Barbara Canlon,
Karolinska Institutet

"Lyckat samarbete"
View article from Biotech Sweden �

"Steget f�re i en exponentiell v�rld"
View article from MedTech Magazine (pdf, 0,5Mb) �

"Inside Wall Street: Biotechs vs. Big Pharma in a Swedish Showdown"
View article from Daily Finance �

"The Swedish-American Life Science Summit"
View article from Nordic Life Science Review (pdf, 0,7Mb) �

"Svenska bioteknikf�retag m�ter amerikanska toppinvesterare"
View article from Ernst & Young �

William Haseltine is a scientist, biotech entrepreneur and frequent SALSS speaker. He did research in cancer and HIV/AIDS while being a professor at Harvard and founder of several companies.
Read his blog here �